BioCentury
ARTICLE | Clinical News

Onfi clobazam regulatory update

December 9, 2013 8:00 AM UTC

FDA issued a drug safety communication and updated the label of Onfi clobazam from H. Lundbeck warning that the seizure drug can cause rare but serious skin reactions, including Stevens-Johnson syndro...